> top > docs > PubMed:10788334 > annotations

PubMed:10788334 JSONTXT

Annnotations TAB JSON ListView MergeView

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer 0005140|0008170
T3 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer 0005140|0008170
T5 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer 0005140|0008170
T7 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer 0005140|0008170
T9 1154-1167 DiseaseOrPhenotypicFeature denotes breast cancer 0004989|0007254
T11 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer 0005140|0008170
T13 1244-1252 DiseaseOrPhenotypicFeature denotes syndrome 0002254

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
333 25-30 GeneOrGeneProduct denotes BRCA1 NCBIGene:672
334 60-81 DiseaseOrPhenotypicFeature denotes breast-ovarian cancer MESH:D061325
335 147-152 GeneOrGeneProduct denotes BRCA1 NCBIGene:672
336 157-162 GeneOrGeneProduct denotes BRCA2 NCBIGene:675
337 260-266 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
338 321-345 DiseaseOrPhenotypicFeature denotes breast or ovarian cancer MESH:D001943|MESH:D010051
339 358-364 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
340 473-499 DiseaseOrPhenotypicFeature denotes breast and ovarian cancers MESH:D001943|MESH:D010051
341 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers MESH:D010051
342 558-572 DiseaseOrPhenotypicFeature denotes breast cancers MESH:D001943
343 666-671 OrganismTaxon denotes woman NCBITaxon:9606
344 718-723 GeneOrGeneProduct denotes BRCA1 NCBIGene:672
345 728-733 GeneOrGeneProduct denotes BRCA2 NCBIGene:675
346 969-974 GeneOrGeneProduct denotes BRCA1 NCBIGene:672
347 981-1000 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities OMIM:604370
348 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer MESH:D010051
349 1096-1121 DiseaseOrPhenotypicFeature denotes breast and ovarian cancer MESH:D001943|MESH:D010051
350 1154-1167 DiseaseOrPhenotypicFeature denotes breast cancer MESH:D001943
351 1199-1204 GeneOrGeneProduct denotes BRCA2 NCBIGene:675
352 1222-1252 DiseaseOrPhenotypicFeature denotes breast-ovarian cancer syndrome MESH:D061325
353 1447-1466 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities OMIM:604370
354 1467-1475 SequenceVariant denotes 5382insC c|INS|5382|C
355 1477-1481 SequenceVariant denotes C61G DBSNP:rs28897672
356 1487-1495 SequenceVariant denotes 4153delA c|DEL|4153|A

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-82 Sentence denotes Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
T2 83-206 Sentence denotes We have undertaken a hospital-based study, to identify possible BRCA1 and BRCA2 founder mutations in the Polish population.
T3 207-440 Sentence denotes The study group consisted of 66 Polish families with cancer who have at least three related females affected with breast or ovarian cancer and who had cancer diagnosed, in at least one of the three affected females, at age <50 years.
T4 441-578 Sentence denotes A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers only.
T5 579-689 Sentence denotes Genomic DNA was prepared from the peripheral blood leukocytes of at least one affected woman from each family.
T6 690-853 Sentence denotes The entire coding region of BRCA1 and BRCA2 was screened for the presence of germline mutations, by use of SSCP followed by direct sequencing of observed variants.
T7 854-914 Sentence denotes Mutations were found in 35 (53%) of the 66 families studied.
T8 915-980 Sentence denotes All but one of the mutations were detected within the BRCA1 gene.
T9 981-1173 Sentence denotes BRCA1 abnormalities were identified in all four families with ovarian cancer only, in 67% of 27 families with both breast and ovarian cancer, and in 34% of 35 families with breast cancer only.
T10 1174-1253 Sentence denotes The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome.
T11 1254-1343 Sentence denotes Seven distinct mutations were identified; five of these occurred in two or more families.
T12 1344-1440 Sentence denotes In total, recurrent mutations were found in 33 (94%) of the 35 families with detected mutations.
T13 1441-1570 Sentence denotes Three BRCA1 abnormalities-5382insC, C61G, and 4153delA-accounted for 51%, 20%, and 11% of the identified mutations, respectively.

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T2 75-81 DiseaseOrPhenotypicFeature denotes cancer 0004992
T3 260-266 DiseaseOrPhenotypicFeature denotes cancer 0004992
T4 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T5 339-345 DiseaseOrPhenotypicFeature denotes cancer 0004992
T6 358-364 DiseaseOrPhenotypicFeature denotes cancer 0004992
T7 484-499 DiseaseOrPhenotypicFeature denotes ovarian cancers 0008170
T8 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers 0008170
T9 558-572 DiseaseOrPhenotypicFeature denotes breast cancers 0007254
T10 1029-1057 DiseaseOrPhenotypicFeature denotes families with ovarian cancer 0016248
T11 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T12 1051-1057 DiseaseOrPhenotypicFeature denotes cancer 0004992
T13 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T14 1115-1121 DiseaseOrPhenotypicFeature denotes cancer 0004992
T15 1154-1167 DiseaseOrPhenotypicFeature denotes breast cancer 0007254
T16 1161-1167 DiseaseOrPhenotypicFeature denotes cancer 0004992
T17 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T18 1237-1243 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1453-1475 SequenceVariant denotes abnormalities-5382insC
T2 1477-1481 SequenceVariant denotes C61G
T3 1487-1495 SequenceVariant denotes 4153delA

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 8-17 GeneOrGeneProduct denotes mutations
T2 25-30 GeneOrGeneProduct denotes BRCA1
T3 113-118 GeneOrGeneProduct denotes based
T4 147-152 GeneOrGeneProduct denotes BRCA1
T5 157-162 GeneOrGeneProduct denotes BRCA2
T6 171-180 GeneOrGeneProduct denotes mutations
T7 434-439 GeneOrGeneProduct denotes years
T8 443-448 GeneOrGeneProduct denotes total
T9 694-700 GeneOrGeneProduct denotes entire
T10 718-723 GeneOrGeneProduct denotes BRCA1
T11 728-733 GeneOrGeneProduct denotes BRCA2
T12 776-785 GeneOrGeneProduct denotes mutations
T13 854-863 GeneOrGeneProduct denotes Mutations
T14 875-880 GeneOrGeneProduct denotes in 35
T15 915-918 GeneOrGeneProduct denotes All
T16 934-943 GeneOrGeneProduct denotes mutations
T17 969-974 GeneOrGeneProduct denotes BRCA1
T18 981-986 GeneOrGeneProduct denotes BRCA1
T19 1020-1023 GeneOrGeneProduct denotes all
T20 1123-1132 GeneOrGeneProduct denotes and in 34
T21 1199-1204 GeneOrGeneProduct denotes BRCA2
T22 1205-1213 GeneOrGeneProduct denotes mutation
T23 1244-1252 GeneOrGeneProduct denotes syndrome
T24 1269-1278 GeneOrGeneProduct denotes mutations
T25 1347-1352 GeneOrGeneProduct denotes total
T26 1364-1373 GeneOrGeneProduct denotes mutations
T27 1385-1390 GeneOrGeneProduct denotes in 33
T28 1430-1439 GeneOrGeneProduct denotes mutations
T29 1447-1452 GeneOrGeneProduct denotes BRCA1
T30 1506-1512 GeneOrGeneProduct denotes for 51
T31 1546-1555 GeneOrGeneProduct denotes mutations

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 25-30 GeneOrGeneProduct denotes BRCA1
T2 147-152 GeneOrGeneProduct denotes BRCA1
T3 157-162 GeneOrGeneProduct denotes BRCA2
T4 718-723 GeneOrGeneProduct denotes BRCA1
T5 728-733 GeneOrGeneProduct denotes BRCA2
T6 969-974 GeneOrGeneProduct denotes BRCA1
T7 981-986 GeneOrGeneProduct denotes BRCA1
T8 1199-1204 GeneOrGeneProduct denotes BRCA2
T9 1244-1252 GeneOrGeneProduct denotes syndrome
T10 1447-1452 GeneOrGeneProduct denotes BRCA1

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T2 260-266 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T4 358-364 DiseaseOrPhenotypicFeature denotes cancer D009369
T5 484-499 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T6 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T7 558-572 DiseaseOrPhenotypicFeature denotes breast cancers D001943
T8 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T9 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T10 1140-1167 DiseaseOrPhenotypicFeature denotes families with breast cancer C562840
T11 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T12 1244-1252 DiseaseOrPhenotypicFeature denotes syndrome D013577
T13 1354-1363 DiseaseOrPhenotypicFeature denotes recurrent D012008

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 157-162 GeneOrGeneProduct denotes BRCA2
T2 728-733 GeneOrGeneProduct denotes BRCA2
T3 1199-1204 GeneOrGeneProduct denotes BRCA2

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T3 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T5 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T7 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T9 1154-1167 DiseaseOrPhenotypicFeature denotes breast cancer 0007254|0004989
T11 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T13 1244-1252 DiseaseOrPhenotypicFeature denotes syndrome 0002254

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T2 260-266 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T4 358-364 DiseaseOrPhenotypicFeature denotes cancer D009369
T5 484-499 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T6 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T7 558-572 DiseaseOrPhenotypicFeature denotes breast cancers D001943
T8 981-1000 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE
T9 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T10 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T11 1140-1167 DiseaseOrPhenotypicFeature denotes families with breast cancer C562840
T12 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T13 1244-1252 DiseaseOrPhenotypicFeature denotes syndrome D013577
T14 1447-1466 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T2 260-266 DiseaseOrPhenotypicFeature denotes cancer D009369
T3 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T4 358-364 DiseaseOrPhenotypicFeature denotes cancer D009369
T5 484-499 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T6 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T7 558-572 DiseaseOrPhenotypicFeature denotes breast cancers D001943
T8 981-1000 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE
T9 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T10 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T11 1140-1167 DiseaseOrPhenotypicFeature denotes families with breast cancer C562840
T12 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T13 1447-1466 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label
T3 1199-1204 GeneOrGeneProduct denotes BRCA2
T2 728-733 GeneOrGeneProduct denotes BRCA2
T1 157-162 GeneOrGeneProduct denotes BRCA2
T13 1447-1466 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE
T12 1229-1243 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T11 1140-1167 DiseaseOrPhenotypicFeature denotes families with breast cancer C562840
T10 1107-1121 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T9 1043-1057 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T8 981-1000 DiseaseOrPhenotypicFeature denotes BRCA1 abnormalities DISEASE
T7 558-572 DiseaseOrPhenotypicFeature denotes breast cancers D001943
T6 516-531 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T5 484-499 DiseaseOrPhenotypicFeature denotes ovarian cancers D010051
T4 358-364 DiseaseOrPhenotypicFeature denotes cancer D009369
T48326 331-345 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T73763 260-266 DiseaseOrPhenotypicFeature denotes cancer D009369
T88982 67-81 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T58179 1487-1495 SequenceVariant denotes 4153delA
T45842 1477-1481 SequenceVariant denotes C61G
T36734 1453-1475 SequenceVariant denotes abnormalities-5382insC

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 260-266 HP_0002664 denotes cancer
T2 321-345 HP_0003002 denotes breast or ovarian cancer
T3 321-345 HP_0100013 denotes breast or ovarian cancer
T4 331-345 HP_0100615 denotes ovarian cancer
T5 339-345 HP_0002664 denotes cancer
T6 358-364 HP_0002664 denotes cancer
T7 473-499 HP_0003002 denotes breast and ovarian cancers
T8 473-499 HP_0100013 denotes breast and ovarian cancers
T9 484-499 HP_0100615 denotes ovarian cancers
T10 492-499 HP_0002664 denotes cancers
T11 516-531 HP_0100615 denotes ovarian cancers
T12 524-531 HP_0002664 denotes cancers
T13 558-572 HP_0003002 denotes breast cancers
T14 558-572 HP_0100013 denotes breast cancers
T15 565-572 HP_0002664 denotes cancers
T16 1043-1057 HP_0100615 denotes ovarian cancer
T17 1051-1057 HP_0002664 denotes cancer
T18 1096-1121 HP_0003002 denotes breast and ovarian cancer
T19 1096-1121 HP_0100013 denotes breast and ovarian cancer
T20 1107-1121 HP_0100615 denotes ovarian cancer
T21 1115-1121 HP_0002664 denotes cancer
T22 1154-1167 HP_0003002 denotes breast cancer
T23 1154-1167 HP_0100013 denotes breast cancer
T24 1161-1167 HP_0002664 denotes cancer
T25 1229-1243 HP_0100615 denotes ovarian cancer
T26 1237-1243 HP_0002664 denotes cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
10788334-0#25#30#gene672 25-30 gene672 denotes BRCA1
10788334-0#67#81#diseaseC0029925 67-81 diseaseC0029925 denotes ovarian cancer
10788334-0#67#81#diseaseC1140680 67-81 diseaseC1140680 denotes ovarian cancer
10788334-8#0#5#gene672 981-986 gene672 denotes BRCA1
10788334-8#173#186#diseaseC0006142 1154-1167 diseaseC0006142 denotes breast cancer
10788334-8#173#186#diseaseC0678222 1154-1167 diseaseC0678222 denotes breast cancer
10788334-9#25#30#gene675 1199-1204 gene675 denotes BRCA2
10788334-9#55#69#diseaseC0029925 1229-1243 diseaseC0029925 denotes ovarian cancer
10788334-9#55#69#diseaseC1140680 1229-1243 diseaseC1140680 denotes ovarian cancer
25#30#gene67267#81#diseaseC0029925 10788334-0#25#30#gene672 10788334-0#67#81#diseaseC0029925 associated_with BRCA1,ovarian cancer
25#30#gene67267#81#diseaseC1140680 10788334-0#25#30#gene672 10788334-0#67#81#diseaseC1140680 associated_with BRCA1,ovarian cancer
0#5#gene672173#186#diseaseC0006142 10788334-8#0#5#gene672 10788334-8#173#186#diseaseC0006142 associated_with BRCA1,breast cancer
0#5#gene672173#186#diseaseC0678222 10788334-8#0#5#gene672 10788334-8#173#186#diseaseC0678222 associated_with BRCA1,breast cancer
25#30#gene67555#69#diseaseC0029925 10788334-9#25#30#gene675 10788334-9#55#69#diseaseC0029925 associated_with BRCA2,ovarian cancer
25#30#gene67555#69#diseaseC1140680 10788334-9#25#30#gene675 10788334-9#55#69#diseaseC1140680 associated_with BRCA2,ovarian cancer

NCBIDiseaseCorpus

Id Subject Object Predicate Lexical cue
T1 60-81 CompositeMention:D061325 denotes breast-ovarian cancer
T2 260-266 DiseaseClass:D009369 denotes cancer
T3 321-345 CompositeMention:D001943|D010051 denotes breast or ovarian cancer
T4 358-364 DiseaseClass:D009369 denotes cancer
T5 473-499 CompositeMention:D001943|D010051 denotes breast and ovarian cancers
T6 516-531 SpecificDisease:D010051 denotes ovarian cancers
T7 558-572 SpecificDisease:D001943 denotes breast cancers
T8 981-1000 DiseaseClass:OMIM:604370 denotes BRCA1 abnormalities
T9 1043-1057 SpecificDisease:D010051 denotes ovarian cancer
T10 1096-1121 CompositeMention:D001943|D010051 denotes breast and ovarian cancer
T11 1154-1167 SpecificDisease:D001943 denotes breast cancer
T12 1222-1252 SpecificDisease:D061325 denotes breast-ovarian cancer syndrome
T13 1447-1466 DiseaseClass:OMIM:604370 denotes BRCA1 abnormalities

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1199-1204 gene:675 denotes BRCA2
T1 1229-1243 disease:C0029925 denotes ovarian cancer
T2 1199-1204 gene:675 denotes BRCA2
T3 1229-1243 disease:C1140680 denotes ovarian cancer
R1 T0 T1 associated_with BRCA2,ovarian cancer
R2 T2 T3 associated_with BRCA2,ovarian cancer

NCBI-Disease-Train

Id Subject Object Predicate Lexical cue database_id
T3097 60-81 CompositeMention denotes breast-ovarian cancer D061325
T3098 260-266 DiseaseClass denotes cancer D009369
T3099 321-345 CompositeMention denotes breast or ovarian cancer D001943|D010051
T3100 358-364 DiseaseClass denotes cancer D009369
T3101 473-499 CompositeMention denotes breast and ovarian cancers D001943|D010051
T3102 516-531 SpecificDisease denotes ovarian cancers D010051
T3103 558-572 SpecificDisease denotes breast cancers D001943
T3104 981-1000 DiseaseClass denotes BRCA1 abnormalities OMIM:604370
T3105 1043-1057 SpecificDisease denotes ovarian cancer D010051
T3106 1096-1121 CompositeMention denotes breast and ovarian cancer D001943|D010051
T3107 1154-1167 SpecificDisease denotes breast cancer D001943
T3108 1222-1252 SpecificDisease denotes breast-ovarian cancer syndrome D061325
T3109 1447-1466 DiseaseClass denotes BRCA1 abnormalities OMIM:604370

NCBI-Disease-Corpus-All

Id Subject Object Predicate Lexical cue database_id
T3097 60-81 CompositeMention denotes breast-ovarian cancer D061325
T3098 260-266 DiseaseClass denotes cancer D009369
T3099 321-345 CompositeMention denotes breast or ovarian cancer D001943|D010051
T3100 358-364 DiseaseClass denotes cancer D009369
T3101 473-499 CompositeMention denotes breast and ovarian cancers D001943|D010051
T3102 516-531 SpecificDisease denotes ovarian cancers D010051
T3103 558-572 SpecificDisease denotes breast cancers D001943
T3104 981-1000 DiseaseClass denotes BRCA1 abnormalities OMIM:604370
T3105 1043-1057 SpecificDisease denotes ovarian cancer D010051
T3106 1096-1121 CompositeMention denotes breast and ovarian cancer D001943|D010051
T3107 1154-1167 SpecificDisease denotes breast cancer D001943
T3108 1222-1252 SpecificDisease denotes breast-ovarian cancer syndrome D061325
T3109 1447-1466 DiseaseClass denotes BRCA1 abnormalities OMIM:604370

NCBI-Disease-Corpus-2stage-All

Id Subject Object Predicate Lexical cue
T1 60-81 CompositeMention denotes breast-ovarian cancer
T2 260-266 DiseaseClass denotes cancer
T3 321-327 SpecificDisease denotes breast
T4 331-345 SpecificDisease denotes ovarian cancer
T5 358-364 DiseaseClass denotes cancer
T6 473-479 SpecificDisease denotes breast
T7 484-499 SpecificDisease denotes ovarian cancers
T8 516-531 SpecificDisease denotes ovarian cancers
T9 558-572 SpecificDisease denotes breast cancers
T10 1043-1057 SpecificDisease denotes ovarian cancer
T11 1096-1102 CompositeMention denotes breast
T12 1107-1121 CompositeMention denotes ovarian cancer
T13 1154-1167 SpecificDisease denotes breast cancer
T14 1222-1252 CompositeMention denotes breast-ovarian cancer syndrome

NCBI-Disease-Corpus-rezarta-All

Id Subject Object Predicate Lexical cue
T1 60-81 CompositeMention denotes breast-ovarian cancer
T2 260-266 DiseaseClass denotes cancer
T3 321-1167 SpecificDisease denotes breast or ovarian cancer and who had cancer diagnosed, in at least one of the three affected females, at age <50 years. A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers only. Genomic DNA was prepared from the peripheral blood leukocytes of at least one affected woman from each family. The entire coding region of BRCA1 and BRCA2 was screened for the presence of germline mutations, by use of SSCP followed by direct sequencing of observed variants. Mutations were found in 35 (53%) of the 66 families studied. All but one of the mutations were detected within the BRCA1 gene. BRCA1 abnormalities were identified in all four families with ovarian cancer only, in 67% of 27 families with both breast and ovarian cancer, and in 34% of 35 families with breast cancer

NCBI-Disease-Corpus-4oGuideline-All

Id Subject Object Predicate Lexical cue
T1 60-81 Modifier denotes breast-ovarian cancer
T2 260-266 DiseaseClass denotes cancer
T3 321-327 Modifier denotes breast
T4 331-345 Modifier denotes ovarian cancer
T5 358-364 DiseaseClass denotes cancer
T6 473-499 CompositeMention denotes breast and ovarian cancers
T7 516-531 SpecificDisease denotes ovarian cancers
T8 558-572 SpecificDisease denotes breast cancers
T9 1043-1057 SpecificDisease denotes ovarian cancer
T10 1096-1121 CompositeMention denotes breast and ovarian cancer
T11 1154-1167 SpecificDisease denotes breast cancer
T12 1222-1252 Modifier denotes breast-ovarian cancer syndrome

NCBI-Disease-Corpus-Simple-All

Id Subject Object Predicate Lexical cue
T1 60-81 CompositeMention denotes breast-ovarian cancer
T2 260-266 DiseaseClass denotes cancer
T3 321-1167 SpecificDisease denotes breast or ovarian cancer and who had cancer diagnosed, in at least one of the three affected females, at age <50 years. A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers only. Genomic DNA was prepared from the peripheral blood leukocytes of at least one affected woman from each family. The entire coding region of BRCA1 and BRCA2 was screened for the presence of germline mutations, by use of SSCP followed by direct sequencing of observed variants. Mutations were found in 35 (53%) of the 66 families studied. All but one of the mutations were detected within the BRCA1 gene. BRCA1 abnormalities were identified in all four families with ovarian cancer only, in 67% of 27 families with both breast and ovarian cancer, and in 34% of 35 families with breast cancer